Warrants allotted

Capital Change Notice

Updated as at February 2025
100680711/3474-1459-1546.3



Me Today has allotted Series 1 (October 2026) Warrants to holders of its shares at 5pm on
7 November 2025 on the basis of one warrant for every two shares held.

Section 1: Issuer information
Name of issuer Me Today Limited
NZX ticker code MEEWA
Class of financial product Series 1 (October 2026) Warrants
ISIN (If unknown, check on NZX website) NZMEEE0004S8
Currency New Zealand dollars
Section 2: Capital change details
Number issued 47,261,238 Series 1 (October 2026)
warrants
Nominal value (if any) N/A
Issue price per security N/A
Nature of the payment (for example, cash or other
consideration)
No consideration is payable for the
warrants
Cash consideration of $0.06 per share is
payable on exercise of the warrants
Amount paid up (if not in full) Paid in full on exercise of the warrant
Percentage of total class of Financial Products
issued (calculated on the number of Financial
Products of the Class, excluding any Treasury
Stock, in existence)
The issue of warrants represents 100% of
this class of warrants
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option
(for example, the exercise price and exercise date)
Vesting occurred on issue on
10 November 2025. The warrants are
able to be converted/exercised to ordinary
shares from 1 October 2026 up to the
expiry date of 5pm on 30 October 2026 by
notice in writing and payment of the
required exercise price in cleared funds.
Reason for issue and specific authority for issue
(the reason for change must be identified here)
Bonus warrant issue
Total number of Financial Products of the Class
after the issue (excluding Treasury Stock) and the
total number of Financial Products of the Class
held as Treasury Stock after the issue.
47,261,238Series 1 (October 2026)
Warrants on issue.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, including a
reference to the rule pursuant to which the issue,
acquisition, or redemption is made
NZX Listing Rule 4.2.1.
Board resolution 10 October 2025
Shareholder approval 30 October 2025

Terms or details of the issue (for example:
restrictions, escrow arrangements)
In the event of any reconstruction, bonus
issue, or rights issue after 10 November
2025, the exercise price/number of
warrants will be adjusted in accordance
with NZX Listing Rules 6.5.2 to 6.5.5.
New ordinary shares issued upon exercise
of the warrants will rank equally with the
ordinary shares already on issue.
Date of issue 10 November 2025
Section 4: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Stephen Sinclair
Contact person for this announcement Stephen Sinclair
Contact phone number +64 21 330 053
Contact email address stephen@metoday.com
Date of release through MAP

10 November 2025

---

Capital Change Notice

Updated as at February 2025
100680711/3465-6645-3055.1



Me Today has allotted Series 2 (October 2027) Warrants to holders of its shares at 5pm on
7 November 2025 on the basis of one warrant for every two shares held.

Section 1: Issuer information
Name of issuer Me Today Limited
NZX ticker code MEEWB
Class of financial product Series 2 (October 2027) Warrants
ISIN (If unknown, check on NZX website) NZMEEE0005S5
Currency New Zealand dollars
Section 2: Capital change details
Number issued 47,261,238 Series 2 (October 2027)
warrants
Nominal value (if any) N/A
Issue price per security N/A
Nature of the payment (for example, cash or other
consideration)
No consideration is payable for the
warrants
Cash consideration of $0.06 per share is
payable on exercise of the warrants
Amount paid up (if not in full) Paid in full on exercise of the warrant
Percentage of total class of Financial Products
issued (calculated on the number of Financial
Products of the Class, excluding any Treasury
Stock, in existence)
The issue of warrants represents 100% of
this class of warrants
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option
(for example, the exercise price and exercise date)
Vesting occurred on issue on
10 November 2025. The warrants are
able to be converted/exercised to ordinary
shares from 1 October 2027 up to the
expiry date of 5pm on 29 October 2027 by
notice in writing and payment of the
required exercise price in cleared funds.
Reason for issue and specific authority for issue
(the reason for change must be identified here)
Bonus warrant issue
Total number of Financial Products of the Class
after the issue (excluding Treasury Stock) and the
total number of Financial Products of the Class
held as Treasury Stock after the issue.
47,261,238 Series 2 (October 2027)
Warrants
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, including a
reference to the rule pursuant to which the issue,
acquisition, or redemption is made
NZX Listing Rule 4.2.1
Board resolution 10 October 2025
Shareholder approval 30 October 2025

Terms or details of the issue (for example:
restrictions, escrow arrangements)
In the event of any reconstruction, bonus
issue, or rights issue after 10 November
2025, the exercise price/number of
warrants will be adjusted in accordance
with NZX Listing Rules 6.5.2 to 6.5.5.
New ordinary shares issued upon exercise
of the warrants will rank equally with the
ordinary shares already on issue.
Date of issue 10 November 2025
Section 4: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Stephen Sinclair
Contact person for this announcement Stephen Sinclair
Contact phone number +64 21 330 053
Contact email address stephen@metoday.com
Date of release through MAP

10 November 2025